|
|
Please type responses here: |
|
First Name:
|
|
|
Last Name:
|
|
|
Email Address:
|
|
|
Retype Email Address:
|
|
|
Title:
|
|
|
Institution:
|
|
|
Phone Number:
|
|
|
City:
|
|
|
State/Province:
|
|
|
Postal/Zip Code:
|
|
|
Country:
|
|
|
Overall, how would you rate your satisfaction with this webinar?
|
Extremely satisfied
Very satisfied
Somewhat satisfied
Dissatisfied
|
|
Your feedback helps your webinar producer and sponsor improve the overall quality of their products and services.
|
|
Would you like more information on this topic?
|
Yes
No
Not sure
|
|
Are you a decision-maker at a blood center?
|
Yes
No
|
|
Are you a decision-maker at a hospital transfusion lab?
|
Yes
No
|
|
Do you have a current GPO affiliation?
|
Yes, primarily Health Trust
Yes, primarily Intalere (formerly Amerinet)
Yes, primarily Premier
Yes, primarily Vizient (formerly Novation & MedAssets)
Yes, but the GPO is not listed (please add your GPO in the space provided)
Mulitple GPOs (please add your affiliated GPO in the space provided)
No, not affiliated
|
|
If your GPO wasn’t mentioned above, please list it here:
|
|
|
Do you currently purchase from Fisher Healthcare?
|
Yes, they’re my primary source
Yes, but I use other distributors and also purchase direct
Only once in a while
No, I only purchase direct
No, I use another distributor
|
|
Would you like to receive EITHER ASCLS PACE credit, program number 354-013-19 (California Agency #0001), OR Florida CE credit OR a certificate of attendance for the session, "Mitigating the Risk of Bacterial Contamination of Platelets - Recent Developments"? (If no, you do not need to complete the following questions.)
|
Yes
No
|
|
Which continuing education credit would you like to receive for this session?
|
PACE
Florida CE Credit
Certificate of Attendance
Neither, I would not like to receive continuing education credit for this session
|
|
If you are planning to submit this session for Florida CE Credit, please provide your Florida license number:
|
|
|
If the following is true, please answer "Yes": I have attended the full instructional time for this program. I understand that completion of the program is necessary to receive the contact hours awarded for the program.
|
Yes
No
|
|
SPEAKER RATING
|
|
To what extent was the speaker knowledgeable, organized and effective during the presentation? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
To what extent did the speaker clarify and focus on the stated objectives? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
To what extent were the speaker's teaching methods & aids appropriate & effective? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
Not applicable
|
|
OBJECTIVES RATING:
To what extent was each objective achieved?
|
|
Review the FDA Guidance for bacterial risk reduction in platelets and its implications. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
|
|
Discuss your options to satisfy FDA Guidance requirements. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
|
|
Describe the advances in rapid testing technology to address the FDA guidance. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
|
|
Identify the ways to extend platelet inventory and save money on platelet outdates. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
|
|
PROGRAM CONTENT RATING
|
|
To what extent did the program content relate to the program's objectives? (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
|
|
Rate the contribution of this session to your overall knowledge of this subject. (1 is Low, 2 is Poor, 3 is High, 4 is Excellent)
|
1
2
3
4
|
|
Rate your overall degree of satisfaction with this session (1 is Low, 2 is Poor, 3 is High, 4 is Excellent).
|
1
2
3
4
|
|
Comments:
|
|
|
Thank you for attending this webinar and completing this evaluation. Questions? Call Whitehat Communications at 434 202 8365.
|
|
|
